Cargando…
“Adjuvant Radioactive iodine 133 ablation in papillary microcarcinoma of thyroid: Saudi Arabian experience”
BACKGROUND: Papillary Microcarcinoma (PMC) of thyroid is a rare type of differentiated thyroid cancer (DTC), which according to the World Health Organization measures 1.0 cm or less. The gold standard of treatment of PMC is still controversy. Our aim was to contribute in resolving the debate on the...
Autores principales: | AL-Qahtani, Khalid Hussain, Al Asiri, Mushabbab, Tunio, Mutahir A., Aljohani, Naji J., Bayoumi, Yasser, Fatani, Hanadi, AlHadab, Abdulrehman |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4666037/ https://www.ncbi.nlm.nih.gov/pubmed/26621255 http://dx.doi.org/10.1186/s40463-015-0108-0 |
Ejemplares similares
-
Erratum to: Adjuvant Radioactive iodine 131 ablation in papillary microcarcinoma of thyroid: Saudi Arabian experience
por: AL-Qahtani, Khalid Hussain, et al.
Publicado: (2016) -
Comparative efficacy, tolerability, and survival outcomes of various radiopharmaceuticals in castration-resistant prostate cancer with bone metastasis: a meta-analysis of randomized controlled trials
por: Tunio, Mutahir, et al.
Publicado: (2015) -
Nasolacrimal duct obstruction following radioactive iodine 131 therapy in differentiated thyroid cancers: review of 19 cases
por: Al-Qahtani, Khalid Hussain, et al.
Publicado: (2014) -
Comparative clinicopathological and outcome analysis of differentiated thyroid cancer in Saudi patients aged below 60 years and above 60 years
por: AL-Qahtani, Khalid Hussain, et al.
Publicado: (2016) -
Calvarium and dura mater as delayed sites of distant metastasis from papillary thyroid carcinoma
por: AL-Qahtani, Khalid Hussain, et al.
Publicado: (2015)